AEMD · Aethlon Medical Inc
$2.83
-0.10 (-3.41%)
At close · Aug 14
Going-concern doubt
— cleared Aug 13, 2026
The latest filing no longer states the doubt (first flagged Jun 10, 2026).
View the 10-Q filed Aug 13, 2026Market Cap
$2.01M
Shares
711,136
Aethlon Medical Inc Earnings Call Transcripts
Every quarterly earnings call for Aethlon Medical Inc (AEMD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY27 · Q1
2026-08-13
First Quarter 2027 Investor Call
Diluted EPS
$-4.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-07-16
Emerging Growth Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q4
2026-06-10
Aethlon Medical Inc Q4 FY2026 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-02-25
Emerging Growth Conference
No reported result — non-financial event
Audio
Transcript
Slides
Annual General Meeting
Investor event
2026-02-19
Annual Meeting of Stockholders
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-02-12
Aethlon Medical Inc Q3 FY2026 Earnings Call
Diluted EPS
$-12.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2025-11-12
Aethlon Medical Inc Q2 FY2026 Earnings Call
Balanced tone
Australian oncology trial progress
Extracellular vesicle (EV) and biomarker data
Long COVID and preclinical R&D
Diluted EPS
$-18.70
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2025-08-13
Aethlon Medical Inc Q1 FY2026 Earnings Call
Positive tone
Australian oncology trial progress
Long COVID and preclinical R&D
Australian R&D tax rebate advantage
Diluted EPS
$-42.42
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-06-27
Aethlon Medical Inc Q4 FY2025 Earnings Call
Positive tone
Hemopurifier oncology trial in Australia
Long COVID / UCSF collaboration
India oncology study approval
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-02-12
Aethlon Medical Inc Q3 FY2025 Earnings Call
Positive tone
Oncology clinical trial progress
Infectious disease / pandemic preparedness
Operating expense reduction and runway
Diluted EPS
$-50.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2024-11-13
Aethlon Medical Inc Q2 FY2025 Earnings Call
Positive tone
Oncology clinical trial in Australia
Australian R&D tax credit
Indian clinical trial expansion
Diluted EPS
$-80.55
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-08-14
Aethlon Medical Inc Q1 FY2025 Earnings Call
Positive tone
Oncology clinical trial progress
Near-term clinical milestones
Personnel changes and restructuring
Diluted EPS
$-138.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-06-27
Aethlon Medical Inc Q4 FY2024 Earnings Call
Positive tone
Oncology clinical trial progress
H5N1 Avian Influenza opportunity
Cash position and finances
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-02-14
Aethlon Medical Inc Q3 FY2024 Earnings Call
Cautious tone
Oncology trial in India/Australia
COVID-19 trial in India
Inconclusive preclinical data
Diluted EPS
$-548.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2023-11-14
Aethlon Medical Inc Q2 FY2024 Earnings Call
Diluted EPS
$-488.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2023-08-10
Aethlon Medical Inc Q1 FY2024 Earnings Call
Diluted EPS
$-540.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-06-28
Aethlon Medical Inc Q4 FY2023 Earnings Call
Revenue
$574,245*
▲ 4278.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-02-13
Aethlon Medical Inc Q3 FY2023 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-496.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2022-11-14
Aethlon Medical Inc Q2 FY2023 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-736.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-08-09
Aethlon Medical Inc Q1 FY2023 Earnings Call
Revenue
$
▼ 100% YoY Diluted EPS
$-760.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-06-28
Aethlon Medical Inc Q4 FY2022 Earnings Call
Revenue
$13,116*
▼ 61.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-02-14
Aethlon Medical Inc Q3 FY2022 Earnings Call
Revenue
$17,117
▼ 97.3% YoY Diluted EPS
$-640.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2021-11-09
Aethlon Medical Inc Q2 FY2022 Earnings Call
Revenue
$131,966
Diluted EPS
$-520.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-08-09
Aethlon Medical Inc Q1 FY2022 Earnings Call
Revenue
$131,966
Diluted EPS
$-640.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-06-24
Aethlon Medical Inc Q4 FY2021 Earnings Call
Revenue
$34,233*
▼ 83.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-02-10
Aethlon Medical Inc Q3 FY2021 Earnings Call
Revenue
$624,871
▲ 51.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2020-10-28
Aethlon Medical Inc Q2 FY2021 Earnings Call
Revenue
$
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-08-11
Aethlon Medical Inc Q1 FY2021 Earnings Call
Revenue
$
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-06-25
Aethlon Medical Inc Q4 FY2020 Earnings Call
Revenue
$206,729*
▲ 158.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-02-10
Aethlon Medical Inc Q3 FY2020 Earnings Call
Revenue
$413,458
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2019-09-30
Aethlon Medical Inc Q2 FY2020 Earnings Call
Revenue
$
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2019-06-30
Aethlon Medical Inc Q1 FY2020 Earnings Call
Revenue
$30,000
▼ 79.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–32 of 32 earnings calls
Key facts
CIK
882291
CUSIP
00808Y604
13F (30d)
19 filings
19 filers
Visit website
Investor relations